| [1] |
QIAO Meng, LEI Chao, CHEN Zijia, ZHANG Qiang, WANG Zhifei.
Analysis and thinking on the status quo of safety item information in the instructions of traditional Chinese patent medicines containing Asari Radix et Rhizoma and its extracts
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1401-1406.
|
| [2] |
YIN Jinjun, WANG Shuwei, SHAO Jiangchao, WANG Bing.
Drug use evaluation of bevacizumab injection based on weighted TOPSIS method
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1421-1426.
|
| [3] |
YANG Liang, TAO Rui, HU Huizi, WANG Zihan, ZHANG Yan, DONG Yan, CHU Zhaoyi, ZHANG Zizhen, GENG Jiahao, LI Shuai, XU Nuo, MA Zengchun, GAO Yue.
Research progress in clinical use of large-dose Radix Aconiti Lateralis Preparata
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 946-949.
|
| [4] |
ZHU Yuanchao, ZHAO Ming, HU Xin, SHI Hong.
Pharmacist-led practice in the management of elderly patients with polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 817-821.
|
| [5] |
WANG Ran, FENG Xin, DU Boran.
Advances in risk assessment and pharmaceutical care of pregnancy medication exposure during perinatal period
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 836-840.
|
| [6] |
FAN Xiucong, DONG Xiaohui, CHEN Danxia, BAO Siwei, MA Yabin.
Pharmaceutical care of a patient with Clostridium difficile infection and urinary tract infection during pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 579-582.
|
| [7] |
ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, Li Guiping, WANG Daohan, LI Shuran, ZHANG Jingsheng, PANG Bo, XU Yingli, ZHOU Lirun, BAO Yanyan, CHEN Mengping, GUO Shanshan, CUI Xiaolan.
Effect of Jinzhen oral liquid on the model of human coronavirus pneumonia and fever epidemic immature adult mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 248-252.
|
| [8] |
ZHANG Yuan, HE Mei.
Pharmaceutical care for a case of Parkinson's syndrome caused by trimetazidine hydrochloride tablets in an elderly patient with renal insufficiency
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 343-345.
|
| [9] |
CAI Yuluo, GUO Jiahui, Wang Xinguo, TIAN Yilong, WANG Meng, NIU Liying, LI Junshan.
Research progress in Yi medicine Valeriana jatamans and predictive analysis of related quality markers
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 348-352.
|
| [10] |
DING Xueli, HUANG Zhengkai, AN Xiaoye, YANG Xiaoxiong, ZHANG Bing, LIN Zhijian.
Visual analysis of ADR induced by Chinese medicine based on CiteSpace knowledge maps
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 196-200.
|
| [11] |
TANG Yan, WANG Jialin, ZHOU Jingya, ZHAO Weigang, DU Boran, HU Dandan, YANG Liping, YANG Yingying, ZHAO Zhe, YUAN Tao.
Pharmaceutical care for a case of fulminant type 1 diabetes with insulin allergy and positive insulin autoantibodies
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1376-1379.
|
| [12] |
WANG Dan, WU Chen, REN Jingtian.
Risk analysis of dextromethorphan abuse
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1097-1099.
|
| [13] |
LIU Bin, SHAO Meiling, CAI Yiran, MA Fengyi, LAN Hong.
Applicability of PDCA cycle in standardization of outpatient prescriptions
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1035-1039.
|
| [14] |
ZHANG Qingxia, JIANG Yongxian, LI Gen, YAN Suying, WANG Yuqin.
Analysis and prevention of medication errors related to stored pharmaceuticals in National Monitoring Network for Clinical Safety Medication
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1040-1044.
|
| [15] |
JIANG Zhuoxi, LIN Zhijian, ZHANG Bing, WANG Yu, XU Huizhe, MAO Qiuyue.
Effect of smilax glabra extract on intestinal barriers in mice with antibiotic-associated diarrhea: an experimental study
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 862-867.
|
